Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study

Abstract Introduction Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir plus lamivudine (DTG + 3TC) are well tolerated and effective in clinical trials. This study aimed to evaluate the safety and efficacy of these two schemes in a real-world setting and to obtain the fi...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Lin Gan, Xiaoxin Xie, Yanhua Fu, Xiaoyan Yang, Shujing Ma, Linghong Kong, Chunli Song, Yebing Song, Tingting Ren, Hai Long
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Adis, Springer Healthcare 2023-10-01
श्रृंखला:	Infectious Diseases and Therapy
विषय:	HIV Integrase strand transfer inhibitor Low-level viraemia Real-world retrospective study Safety
ऑनलाइन पहुंच:	https://doi.org/10.1007/s40121-023-00879-x
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!